Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1st New Schizophrenia Drug in Decades
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other antipsychotics.
Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer side effects.
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way. Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors. All other treatments available for schizophrenia target the dopamine receptors.
FDA Approves Cobenfy, Pioneering New Approach to Schizophrenia Treatment
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This innovative medication marks a significant
US FDA approves new schizophrenia drug
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication that targets specific brain receptors without affecting dopamine pathways.
FDA approves Cobenfy, a first-in-class schizophrenia drug
The US Food and Drug Administration has approved Cobenfy, also known as KarXT, a new schizophrenia treatment. The drug was developed by Karuna Therapeutics, which was bought by Bristol Myers Squibb (BMS) last year for $14 billion.
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.
FDA Approves First New Schizophrenia Drug In 30 Years: Cobenfy Offers Hope With Fewer Side Effects | Details
The FDA has approved Cobenfy, the first new schizophrenia treatment in 30 years, offering a novel approach with fewer side effects. Developed by Karuna Therapeutics, the drug is set to provide new hope for patients.
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.
FDA Approves the First New Type of Schizophrenia Drug in Decades
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle movement, and sedation — that can cause patients to discontinue treatment.
Valley News Live
15h
FDA approves new drug for schizophrenia, described as a potential ‘game changer’
The US Food and
Drug
Administration (FDA) recently approved a new medication treatmeant, called
Cobenfy
, which is a ...
6d
Homeless man living inside city clothes bin says 'it's the comfiest bed I've had'
Nigel, 52, has slept rough on and off for most of his life and says his home of four weeks of a clothes bin in Birmingham has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Dockworkers launch strike
Pete Rose dies at 83
Helene wreaks havoc
NBA Hall of Famer dies
Medical records breached
Tony-winning star dies
Explosive devices found
TX fraud probe shut down
Settlement checks delayed
Wausau drop box replaced
CA bans legacy admissions
FCC probing outage
Hand count rule challenged
Japan's new prime minister
More troops to Middle East
Asylum restrictions extended
194K Jeep SUVs recalled
NH voter ID law challenged
To lay off 2,900 employees
SpaceX Falcon 9 grounded
Lose 'superhero' trademark
Settles data breach cases
'Sing Sing' actor exonerated
Mich. nuclear plant to restart
Red Sox honor radio voice
Israel announces operation
Signals more rate cuts
Feedback